Literature DB >> 11348424

Effects of 5-fluorouracil on cell cycle arrest and toxicity induced by X-irradiation in normal mammalian cells.

U Nylén1, E Cekan, G B Jonasson, F Lewin, S Skog.   

Abstract

UNLABELLED: From clinical studies in cancer patients and experimental in vitro studies, there is evidence of an increased cytotoxic effect, and even synergy, when irradiation is combined with 5-fluorouracil (5-FU). The mechanism for this is unclear.
MATERIALS AND METHODS: Mouse fetuses (C3H) have been exposed in vivo to X-irradiation and 5-fluorouracil (5-FU) as single agents or in combination. Cell proliferation, cell cycle progression, fetal survival and incidence of fetal malformations have been studied.
PURPOSE: The aim of this study was to determine possible synergistic cytotoxic effects when 5-FU and ionizing radiation were combined, particularly concerning the regulation of cell cycle progression in proliferating, non malignant mammalian cells in vivo.
RESULTS: The combination of low-toxic doses of X-irradiation and 5-FU had a synergistic toxic effect in nonmalignant mouse fetuses in vivo. The cell cycle regulation was perturbed and the radiation-induced G2-arrest was eradicated by 5-FU during the initial hours.
CONCLUSIONS: The time for repair of radiation induced DNA-damage is probably reduced, which may explain the increased toxicity of this combination.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11348424      PMCID: PMC6495968          DOI: 10.1046/j.1365-2184.2001.00200.x

Source DB:  PubMed          Journal:  Cell Prolif        ISSN: 0960-7722            Impact factor:   6.831


  27 in total

1.  Sensitive stages for the production of developmental abnormalities in mice with 5-fluorouracil.

Authors:  C P DAGG
Journal:  Am J Anat       Date:  1960-03

Review 2.  Biologic rationale of combined radiotherapy and chemotherapy.

Authors:  K K Fu; T L Phillips
Journal:  Hematol Oncol Clin North Am       Date:  1991-08       Impact factor: 3.722

3.  Combined effect of x radiation and 5-fluorouracil on survival of transplanted leukemic cells.

Authors:  T Vietti; F Eggerding; F Valeriote
Journal:  J Natl Cancer Inst       Date:  1971-10       Impact factor: 13.506

Review 4.  Fluorinated pyrimidines and their nucleosides.

Authors:  C Heidelberger; P V Danenberg; R G Moran
Journal:  Adv Enzymol Relat Areas Mol Biol       Date:  1983

5.  DNA synthesis after combined treatment with cisplatin and 5-fluorouracil of a mouse ascites tumor growing in vivo.

Authors:  S Skog; F Lewin; T Heiden; B Tribukait
Journal:  Anticancer Drugs       Date:  1994-02       Impact factor: 2.248

6.  Specific inhibition of pre-ribosomal RNA processing in extracts from the lymphosarcoma cells treated with 5-fluorouracil.

Authors:  K Ghoshal; S T Jacob
Journal:  Cancer Res       Date:  1994-02-01       Impact factor: 12.701

Review 7.  Coteratogenic effects of caffeine.

Authors:  A Sivak
Journal:  Regul Toxicol Pharmacol       Date:  1994-02       Impact factor: 3.271

Review 8.  Current status of radiation sensitization by fluoropyrimidines.

Authors:  A T Pu; J M Robertson; T S Lawrence
Journal:  Oncology (Williston Park)       Date:  1995-08       Impact factor: 2.990

9.  Flow cytometric analysis of X-ray sensitivity in ataxia telangiectasia.

Authors:  N S Rudolph; S A Latt
Journal:  Mutat Res       Date:  1989-03       Impact factor: 2.433

10.  Dependence of 5-fluorouracil-mediated radiosensitization on DNA-directed effects.

Authors:  T S Lawrence; M A Davis; J Maybaum
Journal:  Int J Radiat Oncol Biol Phys       Date:  1994-06-15       Impact factor: 7.038

View more
  2 in total

Review 1.  Combination Therapy, a Promising Approach to Enhance the Efficacy of Radionuclide and Targeted Radionuclide Therapy of Prostate and Breast Cancer.

Authors:  Tyrillshall S T Damiana; Simone U Dalm
Journal:  Pharmaceutics       Date:  2021-05-07       Impact factor: 6.321

Review 2.  Local Radiotherapy Affects Drug Pharmacokinetics-Exploration of a Neglected but Significant Uncertainty of Cancer Therapy.

Authors:  Yu-Jen Chen; Tung-Hu Tsai; Li-Ying Wang; Chen-Hsi Hsieh
Journal:  Technol Cancer Res Treat       Date:  2017-10-31
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.